Loading...
Printed on 6/29/2026
For informational purposes only. This is not medical advice.
The TTKG estimates the potassium concentration gradient in the cortical collecting duct, reflecting aldosterone activity and renal potassium secretion. It helps differentiate renal from extrarenal causes of potassium disorders. Valid only when urine osmolality exceeds serum osmolality. For complete renal tubular workup, combine with [Urine Anion Gap Calculator](/tools/urine-anion-gap) and [FENa Calculator](/tools/fena-calculator). Assess overall acid-base context with [Anion Gap Calculator](/tools/anion-gap) and [ABG Interpreter](/tools/abg-interpreter). Monitor renal function with [eGFR Calculator](/tools/egfr-calculator).
Formula: TTKG = (Urine K ÷ Serum K) ÷ (Urine Osm ÷ Serum Osm)
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
Collect a spot urine sample and simultaneous blood sample for: urine potassium (mEq/L), serum potassium (mEq/L), urine osmolality (mOsm/kg), and serum osmolality (mOsm/kg). Urine osmolality must exceed serum osmolality for the TTKG to be valid — this confirms that ADH is active and the kidney is concentrating urine, ensuring water reabsorption in the collecting duct that the formula's assumptions require.
TTKG = (Urine K / Serum K) × (Serum Osm / Urine Osm). This formula corrects the urine K/serum K ratio for water reabsorption in the medullary collecting duct, estimating the K concentration ratio at the cortical collecting duct where aldosterone acts. A high TTKG indicates high aldosterone activity driving potassium secretion; a low TTKG indicates inadequate aldosterone activity or resistance.
In hyperkalemia: TTKG below 5-7 suggests impaired renal K excretion (hypoaldosteronism, Type 4 RTA, aldosterone resistance); TTKG above 7-8 suggests appropriate renal K excretion (extrarenal cause: cell lysis, intake). In hypokalemia: TTKG above 3-4 suggests renal K wasting (hyperaldosteronism, diuretics, Bartter/Gitelman); TTKG below 2 suggests extrarenal K loss (GI losses, poor intake, transcellular shift).
Nephrologists, endocrinologists, hospitalists
A patient has persistent hyperkalemia (K 6.2 mEq/L) despite stopping ACE inhibitors and with adequate urine output. TTKG is 3 (below 5-7 threshold for hyperkalemia) — indicating inadequate renal K excretion. Differential: hypoaldosteronism (Addison's disease, Type 4 RTA in diabetic nephropathy, ACE/ARB effect), aldosterone resistance (pseudohypoaldosteronism), or renal tubular dysfunction. Next: check renin and aldosterone levels. TTKG less than 5 with K above 5.5 requires aldosterone axis evaluation.
Endocrinologists, hypertension specialists
A patient with hypertension and unprovoked hypokalemia (K 3.0 mEq/L) has TTKG of 8 (above 4-5 threshold for hypokalemia). This indicates renal K wasting driven by high aldosterone — inappropriate urinary potassium loss given low serum K. This pattern, combined with hypertension, strongly suggests primary hyperaldosteronism (Conn's syndrome). Confirmatory testing: plasma aldosterone-to-renin ratio, CT adrenal, adrenal vein sampling.
Hospitalists, gastroenterologists
A patient with chronic diarrhea has K 2.8 mEq/L. TTKG is 1.5 (below 2) — the kidney is appropriately conserving potassium. This confirms extrarenal K loss (GI losses from diarrhea, vomiting, laxative abuse, ileostomy). Treatment: oral or IV potassium replacement. This pattern differs from a patient with diuretic use: diuretics cause TTKG above 4 (renal wasting). TTKG quickly directs the workup without extensive additional testing.
Endocrinologists, emergency physicians
Addison's disease causes deficiency of both aldosterone and cortisol. Low aldosterone impairs potassium excretion, producing hyperkalemia. TTKG is characteristically below 5 despite hyperkalemia — the kidney cannot secrete K without aldosterone. Combined with hyponatremia (low aldosterone also impairs sodium reabsorption), eosinophilia, and clinical features of adrenal crisis, TTKG less than 5 in hyperkalemia supports Addison's disease evaluation with morning cortisol and ACTH stimulation test.
Nephrologists, hospitalists
Type 4 RTA (hyporeninemic hypoaldosteronism) is the most common cause of persistent hyperkalemia in diabetic patients with CKD. It presents with mild metabolic acidosis (normal AG), hyperkalemia, and TTKG below 5. Classic patient: long-standing diabetes with creatinine 1.5-2.5 mg/dL, K persistently 5.5-6.5 mEq/L, HCO3- 18-20 mEq/L. TTKG confirms inadequate aldosterone effect on collecting duct. Treatment: dietary K restriction, fludrocortisone (mineralocorticoid replacement), or loop diuretics.
The TTKG formula corrects for water reabsorption in the collecting duct, which requires that ADH is active and the kidney is concentrating urine. If urine osmolality is less than or equal to serum osmolality (patient is maximally diluting urine — large water intake, central DI, or nephrogenic DI), the TTKG formula's assumptions are violated and the result is meaningless. Always check this prerequisite before interpreting TTKG.
The urine potassium-to-creatinine ratio (uK/Cr, in mEq/g) is increasingly preferred over TTKG because it does not require urine osmolality: uK/Cr above 20 mEq/g suggests renal K wasting; below 15 suggests extrarenal loss. Kamel et al. (QJM 1998) and Choi et al. (Kidney Int 2012) challenged TTKG's validity assumptions, making uK/Cr a simpler and arguably more reliable alternative. Check your nephrology team's preferred approach.
TTKG is a useful screening tool but not sufficient for definitive diagnosis. For complete mineralocorticoid axis evaluation: measure plasma renin activity (PRA) and aldosterone simultaneously. Pattern interpretation: Low renin + high aldosterone = primary hyperaldosteronism (Conn's). High renin + high aldosterone = secondary hyperaldosteronism (renovascular hypertension). Low renin + low aldosterone = hyporeninemic hypoaldosteronism (Type 4 RTA). High renin + low aldosterone = adrenal insufficiency (Addison's).
Normal TTKG in the context of hyperkalemia (K above 5.0 mEq/L) should be above 7-8, reflecting the kidney appropriately trying to excrete excess potassium. A TTKG below 5 with hyperkalemia is abnormal — the kidney is failing to excrete potassium adequately. This virtually always indicates hypoaldosteronism or aldosterone resistance. EKG changes from hyperkalemia (peaked T waves, PR prolongation, wide QRS) require immediate treatment regardless of TTKG.
Bartter syndrome (loop of Henle transporter defect) and Gitelman syndrome (distal tubule NaCl cotransporter defect) both cause inappropriate renal potassium wasting with TTKG above 4 in the setting of hypokalemia. Gitelman also causes hypomagnesemia and hypocalciuria — useful distinguishing features. These are rare inherited tubulopathies but important to recognize because treatment differs from other causes of hypokalemia (requires lifelong potassium replacement and magnesium supplementation).
Adequate sodium delivery to the cortical collecting duct is required for potassium secretion to occur. If urine sodium is below 25 mEq/L, there is insufficient sodium for potassium exchange at the collecting duct — a low TTKG in this setting may simply reflect inadequate sodium delivery, not true hypoaldosteronism. Check urine sodium alongside TTKG. If urine Na is below 25, the TTKG interpretation is unreliable.
Renin-angiotensin-aldosterone system (RAAS) blockers (ACE inhibitors, ARBs, aliskiren) reduce aldosterone production, potentially lowering TTKG and causing hyperkalemia — especially in patients with pre-existing CKD or diabetes. TTKG below 5 in a hyperkalemic patient on RAAS blockade may reflect drug effect rather than intrinsic disease. Stopping the offending drug and repeating TTKG can help distinguish drug effect from underlying hypoaldosteronism.
TTKG developed by West and Fernandez (J Am Soc Nephrol 1986). Urine K/Cr ratio as alternative: Kamel et al. (QJM 1998). TTKG validity challenged: Choi et al. (Kidney Int 2012) who questioned urea permeability assumptions. Current nephrology textbooks (Brenner and Rector, The Kidney) reference TTKG in potassium disorder evaluation. KDIGO 2012 CKD guidelines address hyperkalemia management. Primary hyperaldosteronism diagnosis: Funder et al. (J Clin Endocrinol Metab 2016). Type 4 RTA review: DuBose (Am J Kidney Dis 2019).
The TTKG estimates the potassium concentration gradient across the cortical collecting duct, reflecting the kidney's ability to secrete or conserve potassium under aldosterone influence. In hyperkalemia, a TTKG below 7 suggests that the kidney is not appropriately excreting potassium, pointing to a renal cause such as hypoaldosteronism, aldosterone resistance, or collecting duct dysfunction. A TTKG above 7 in hyperkalemia suggests the kidney is responding appropriately and the cause is likely extrarenal (e.g., cell lysis, rhabdomyolysis, massive intake).
In hypokalemia, a TTKG above 3 indicates inappropriate renal potassium wasting, which may be due to hyperaldosteronism, diuretic use, or renal tubular disorders such as Bartter or Gitelman syndrome. A TTKG below 2 in hypokalemia suggests the kidney is conserving potassium appropriately, and losses are extrarenal (GI losses, inadequate intake, transcellular shift).
Use the TTKG when evaluating the etiology of unexplained hypokalemia or hyperkalemia. It is most valuable when the clinical picture does not clearly point to a renal versus extrarenal cause. For example, in a patient with hyperkalemia but no obvious cause (no renal failure, no potassium load, no cell lysis), the TTKG can help determine whether aldosterone deficiency or resistance is contributing.
The TTKG is valid only when certain prerequisites are met: the urine osmolality must exceed the serum osmolality (indicating ADH activity and water reabsorption in the collecting duct), and the urine sodium should be above 25 mEq/L (ensuring adequate sodium delivery to the collecting duct for potassium secretion). If these conditions are not met, the TTKG result is unreliable.
The theoretical basis of the TTKG has been questioned in recent years. The formula assumes that urea and water are the only substances reabsorbed in the medullary collecting duct and that potassium is neither secreted nor reabsorbed there. Studies have shown that these assumptions are not entirely valid, and some nephrology experts have moved away from routine TTKG use.
The TTKG cannot distinguish between specific causes within the renal or extrarenal categories. For example, a low TTKG in hyperkalemia does not differentiate between type 4 RTA, ACE inhibitor effect, or primary hypoaldosteronism. Additional testing (aldosterone levels, renin activity, urine electrolytes) is needed for a definitive diagnosis. Despite its limitations, the TTKG remains a useful bedside tool for initial assessment when interpreted cautiously alongside clinical context.
For related assessments, see Anion Gap, Urine Anion Gap and FENa Calculator.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Calculate anion gap and albumin-corrected anion gap to evaluate metabolic acidosis, narrow differential diagnosis, and monitor treatment response.
OpenNephrologyCalculate the urine anion gap to differentiate GI from renal causes of non-anion gap metabolic acidosis. Negative UAG suggests GI bicarbonate loss; positive UAG suggests renal tubular acidosis.
OpenNephrologyCalculate the Fractional Excretion of Sodium (FENa) to differentiate pre-renal azotemia (FENa <1%) from intrinsic renal disease such as ATN (FENa >2%) in acute kidney injury.
Open